AbCellera Investor Conference Presentation Deck

BANK OF AMERICA TECH SOLUTIONS FOR DRUG DISCOVERY COPYRIGHT © ABCELLERA 4 THE PROBLEM LIMITED TECH & LIMITED ACCESS LIMITS IMPACT Drug developers focus on getting one drug candidate to the finish line. The result is a chronic underinvestment in the technologies to make the process of drug development better. Drug development fails too often, takes too long and costs too much. ~$3 billion + The average cost of drug development. ~9.4 to 12 years The time it takes an average antibody drug from initiation to approval. >90% failure rate

View entire presentation